WeightWatchers Sees Revenue Boost From Semaglutide Prescriptions Despite Subscriber Drop

Why are Nvidia and AMD paying US on China chip sales? How will Trump’s DC police takeover impact crime rates? What caused the explosion at Pennsylvania steel plant? Why is Ford investing billions in low-cost electric vehicles? How does the new ESPN-Fox streaming bundle affect sports fans? What’s behind the surge in lithium stock prices? Why did the US pause higher tariffs on China?

WeightWatchers Sees Revenue Boost From Semaglutide Prescriptions Despite Subscriber Drop

benzinga.com/markets/earnings/25/08/47030317/weightwatchers-sees-revenue-boost-from-semaglutide-prescriptions-despite-subscriber-drop

WW International, Inc. (NASDAQ:WW) stock surged Monday after it reported second-quarter 2025 combined revenues of $189 million, down 6% from the prior year. Growth in Clinical subscriptions offset declines in the Behavioral segment.
Clinical subscription revenues rose 55% to $30.59…

This story appeared on benzinga.com, 2025-08-11 13:29:09.